For more than 10 years (since 2015), I have been working with great passion as a gynaecologist. Over the years, I have developed a strong interest in reproductive medicine (hormonal disorders) and benign gynaecological conditions. One of the most important lessons I have learned is that it is essential to fully understand the patient’s symptoms and concerns. This requires careful listening and asking the right questions when needed. When it comes to treatment, I believe it is equally important that you fully understand your condition and the available treatment options. You can expect clear and detailed explanations about the different possibilities, including the potential advantages and disadvantages for your specific situation. Together, we can decide on the treatment that suits you best (shared decision-making).
Specialty / areas of interest
Reproductive medicine: recurrent miscarriage, PCOS, oligo/amenorrhoea (absence of menstruation), premature menopause, and (peri)menopause
Benign gynaecology and minimally invasive surgery: contraception, endometriosis, fibroid care, ovarian cysts, abnormal bleeding, vulvar and vaginal disorders
Languages
Dutch, English
Work Experience
2026 – present: Gynaecologist, Acibadem
2015 – present: Gynaecologist and Head of Reproductive Medicine, Maasstad Ziekenhuis
Education
2010 – 2015: Residency Training in Gynaecology, Erasmus MC / Ruwaard van Putten Hospital
2004 – 2009: Resident Physician in Gynaecology and PhD Researcher, Erasmus MC
2003: Medical Degree
Additional Activities
Ambassador for Smoke-Free Start
Member of Nederlandse Vereniging voor Obstetrie en Gynaecologie (NVOG) and European Society of Human Reproduction and Embryology (ESHRE)
PhD Thesis
Promotie 21-01-2015:Early Pregnancy Development and Obstetric Outcome
Medical Publications
• Van Oppenraaij RHF, Goddijn M, Lok CAR, Exalto N. De jonge zwangerschap; revisie van de Nederlandse benamingen voor klinische en echoscopische bevindingen. NTvG 2008;152:20-4
• Van Oppenraaij RHF, Koning AHJ, Lisman BA, van den Hoff MJB, Boer K, van der Spek PJ, Steegers EAP, Exalto N. Vasculogenesis and angiogenesis in the human placenta; an innovative 3 dimensional study using an immersive Virtual Reality system. Placenta 2009; 30:220-2
• Van Oppenraaij RHF, Jauniaux E, Christiansen OB, Horcajadas JA, Farquharson RG, Exalto N. Predicting adverse obstetric outcome after early pregnancy complications: a review. On Behalf of ESHRE Special Interest Group for Early Pregnancy (SIGEP). Hum Repr Upd 2009; 15;409-21
• Van Oppenraaij RHF, Nik H, Heathcote L, McPartland J, Turner MA, Quenby S, Steegers EAP, Exalto, N. Compromised chorionic villous vascularization in idiopathic second trimester fetal loss. Early Hum Dev 2010;86:469-72
• Rousian M, Koning AH, van Oppenraaij RHF, Hop WC, Verwoerd-Dikkeboom CM, Spek PJ van der, Exalto N, Steegers EAP. An innovative virtual reality technique for automated human embryonic volume measurements. Hum Reprod 2010;25:2210-6
• Jauniaux E, van Oppenraaij RHF, Burton GJ. Obstetric outcome after early placental complications. Curr Opin Obstet Gynecol 2010;22:452-7
• Van Oppenraaij RHF, Bergen NE, Duvekot JJ, de Krijger RR, Steegers EAP, Exalto N. Placental vascularization in early onset fetal growth restriction and preeclampsia. Reprod Sci 2011;18:586-93
• Drury JA, Nik H, van Oppenraaij RHF, Tang AW, Turner MA, Quenby S. Endometrial cell counts in recurrent miscarriage: a comparison of counting methods. Histopathology 2011;59:1156-62
• Van Oppenraaij RHF, Koning AH, van den Hoff MJ, Spek PJ van der, Steegers EAP, Exalto N. The effect of smoking on early chorionic villous vascularisation. Placenta 2012;33:645-51
• Kolte AM, van Oppenraaij RHF, Quenby S, Farquharson RG, Stephenson M, Goddijn M, Christiansen OB. Non-visualized pregnancy losses are prognostically important for unexplained recurrent miscarriage. Hum Reprod 2014;59:931-7
• Van Oppenraaij RHF, Eilers P, Willemsen S, Dunné F van, Exalto N, Steegers EAP. Determinants of number-specific recall error of last menstrual period: a retrospective cohort study. BJOG 2015;122:835-41
• Van Hoogenhuijze et al. Endometrial scratching in women with one failed IVF/ICSI cycle-outcomes of a radomised controlled trial (SCRaTCH). Hum Reprod 2021;36;87-98
• Van Hoogenhuijze et al. Economic evaluatie of endometrial scratching before the second IVF/ICSI treatment: a cost-effectiveness analysis of a randomized controlled trial (SCRaTCH trial). Hum Reprod 2022:37;254-63
• De Ligny et al. Antioxidant treatment and the chance to conceive in men seekng fertility care: The summer RCT. JAMA Netw Open 2025:8;e2532405. Do: 10.1001/jamanetworkopen.2025.32405.
• Van der Wel et al. Myo-inositol supplementation to prevent pregnancy complications in PCOS: a RCT. JAMA 2025:7:334(13):1151-1159.
